Petra Mandysová1,2, Edvard Ehler3,4, Jana Škvrňáková5,4, Michal Černý6, Iva Bártová5, Arnošt Pellant5,4. 1. Department of Neurology, Pardubice Hospital, Hospitals of the Pardubice Region, Czech Republic. petra.mandysova@upce.cz. 2. Faculty of Health Studies, University of Pardubice, Czech Republic. petra.mandysova@upce.cz. 3. Department of Neurology, Pardubice Hospital, Hospitals of the Pardubice Region, Czech Republic. 4. Faculty of Health Studies, University of Pardubice, Czech Republic. 5. Department of Otorhinolaryngology and Head and Neck Surgery, Pardubice Hospital, Hospitals of the Pardubice Region, Czech Republic. 6. Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Králové, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic.
Abstract
AIM: The purpose of this study was to develop a revised version of the Brief Bedside Dysphagia Screening Test for determining penetration/aspiration risk in patients prone to dysphagia. The priority was to achieve high sensitivity and negative predictive value. METHODS: The study screeners conducted bedside assessment of the swallowing function in 157 patients with a neurological (mainly stroke) or an ear, nose, and throat diagnosis (mainly head and neck cancer). The results were compared with a gold standard, flexible endoscopic examination of swallowing. RESULTS: For the neurological subgroup (N = 106), eight statistically significant bedside assessment items were combined into the Brief Bedside Dysphagia Screening Test-Revised (BBDST-R). Cut-off score 1 produced the highest sensitivity (95.5%; 95% confidence interval CI [CI]: 84.9-98.7%) and negative predictive value (88.9%; 95% CI 67.2-96.9%). CONCLUSION: The BBDST-R is suitable for dysphagia screening in departments caring for patients with neurological conditions.
AIM: The purpose of this study was to develop a revised version of the Brief Bedside Dysphagia Screening Test for determining penetration/aspiration risk in patients prone to dysphagia. The priority was to achieve high sensitivity and negative predictive value. METHODS: The study screeners conducted bedside assessment of the swallowing function in 157 patients with a neurological (mainly stroke) or an ear, nose, and throat diagnosis (mainly head and neck cancer). The results were compared with a gold standard, flexible endoscopic examination of swallowing. RESULTS: For the neurological subgroup (N = 106), eight statistically significant bedside assessment items were combined into the Brief Bedside Dysphagia Screening Test-Revised (BBDST-R). Cut-off score 1 produced the highest sensitivity (95.5%; 95% confidence interval CI [CI]: 84.9-98.7%) and negative predictive value (88.9%; 95% CI 67.2-96.9%). CONCLUSION: The BBDST-R is suitable for dysphagia screening in departments caring for patients with neurological conditions.
Authors: Elizabeth Boaden; Jane Burnell; Lucy Hives; Paola Dey; Andrew Clegg; Mary W Lyons; C Elizabeth Lightbody; Margaret A Hurley; Hazel Roddam; Elizabeth McInnes; Anne Alexandrov; Caroline L Watkins Journal: Cochrane Database Syst Rev Date: 2021-10-18